Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVO) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Alvotech (ALVO) over the last 5 years, with Q3 2025 value amounting to -$26.8 million.

  • Alvotech's Change in Accured Expenses fell 11198.58% to -$26.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.0 million, marking a year-over-year decrease of 3814.17%. This contributed to the annual value of -$5.2 million for FY2023, which is 7576.69% up from last year.
  • As of Q3 2025, Alvotech's Change in Accured Expenses stood at -$26.8 million, which was down 11198.58% from $20.5 million recorded in Q2 2025.
  • Over the past 5 years, Alvotech's Change in Accured Expenses peaked at $20.5 million during Q2 2025, and registered a low of -$26.8 million during Q3 2025.
  • Over the past 5 years, Alvotech's median Change in Accured Expenses value was -$7.1 million (recorded in 2024), while the average stood at -$7.4 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 674646.15% in 2022, then skyrocketed by 179630.66% in 2025.
  • Quarter analysis of 5 years shows Alvotech's Change in Accured Expenses stood at $4.5 million in 2021, then tumbled by 580.22% to -$21.4 million in 2022, then soared by 75.77% to -$5.2 million in 2023, then tumbled by 175.94% to -$14.3 million in 2024, then plummeted by 87.76% to -$26.8 million in 2025.
  • Its Change in Accured Expenses was -$26.8 million in Q3 2025, compared to $20.5 million in Q2 2025 and -$12.4 million in Q1 2025.